Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom
Citation
Wolowacz, S., Brockbank, J., Sunderland, TJ., & Gonschior, AK. (2013). Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom. Value in Health, 16(7), A526-A526.